The development of malignant melanoma is a highly complex process, which is still poorly understood. A majority of human melanomas are found to express a few oncogenic proteins, such as mutant RAS and BRAF variants. However, these oncogenes are also found in nevi, and it is now a well-accepted fact that their expression alone leads to senescence. This renders the understanding of senescence escape mechanisms an important point to understand tumor development. Here, we approached the question of senescence evasion by expressing the transcription factor v-myc myelocytomatosis viral oncogene homolog (c-MYC), which is known to act synergistically with many oncogenes, in melanocytes. We observed that MYC drives the evasion of reactiveoxygen stress-induced melanocyte senescence, caused by activated receptor tyrosine kinase signaling. Conversely, MIZ1, the growth suppressing interaction partner of MYC, is involved in mediating melanocyte senescence. Both, MYC overexpression and Miz1 knockdown led to a strong reduction of endogenous reactive-oxygen species (ROS), DNA damage and senescence. We identified the cystathionase (CTH) gene product as mediator of the ROS-related MYC and MIZ1 effects. Blocking CTH enzymatic activity in MYC-overexpressing and Miz1 knockdown cells increased intracellular stress and senescence. Importantly, pharmacological inhibition of CTH in human melanoma cells also reconstituted senescence in the majority of cell lines, and CTH knockdown reduced tumorigenic effects such as proliferation, H 2 O 2 resistance and soft agar growth. Thus, we identified CTH as new MYC target gene with an important function in senescence evasion.
INTRODUCTION
Melanomas are characterized by the presence of distinct genetic lesions, such as N-RAS Q61K , BRAF V600E , or GNAQ Q209L , the latter being found in uveal melanoma. 1, 2 At least N-RAS and BRAF possess the capacity to induce the potentially oncogenic transcription factor v-myc myelocytomatosis viral oncogene homolog (c-MYC), 3, 4 and amplifications of c-MYC are commonly observed in uveal melanoma. 5 c-MYC fulfills several pro-tumorigenic functions. A high c-MYC expression enhances aggressive melanoma growth in SCID mice 6 and goes along with interferon-a resistance in human melanoma. 7 c-MYC downregulation can sensitize melanoma cells to chemo-and radiotherapy. 8, 9 Many human oncogenes do not lead to tumorigenic cell transformation when expressed in an otherwise non-tumorigenic cellular background, but instead cause oncogene-induced senescence (OIS). However, overexpression of c-MYC in the presence of senescence inducers such as constitutively active BRAF or STAT5A can prevent senescence and allow cell growth. 10, 11 Part of the pro-tumorigenic function of c-MYC is attributed to its interaction with the transcription factor MIZ1. In the absence of c-MYC, cellular stress such as ultraviolet exposure induces binding of MIZ1 to the promoters of p21 CIP/WAF1 and p15 INK4B , thereby leading to enhanced gene expression and eventually to cell cycle arrest. [12] [13] [14] Furthermore, MIZ1 is directly involved in the ultraviolet-mediated DNA damage response by promoting the activity of ataxia telangiectasia and Rad3-related (ATR). C-MYC can counteract these effects by forming a complex with MIZ1, thereby blocking its interaction with other proteins, which affects both transcriptional activity and signaling activity of MIZ1. 12, 15 We previously described that activation of an oncogenic receptor tyrosine kinase in murine melanocytes leads to reactive-oxygen species (ROS)-dependent senescence when expressed at high levels. 16 Here, we are using this melanocyte model to investigate the mechanism of senescence prevention by c-MYC and its interaction partner MIZ1. We show that both proteins affect senescence by modulating intracellular stress levels. Using microarray and chromatin immunoprecipitation analyses, we found that the cysteine-generating enzyme cystathionase (CTH) is regulated by both proteins. Interestingly, CTH is also strongly expressed in melanoma cell lines, mostly in a MYC-dependent manner, and is required for the prevention of DNA damage and senescence.
RESULTS
To contribute to a better understanding of melanocyte senescence in response to cellular oncogenic stress, we use a system that allows senescence induction in a tightly controlled way. The 'HERmrk' melan-a cells are mouse melanocytes expressing a human epidermal growth factor (EGF) receptor ('HER') whose intracellular domain has been replaced by the corresponding part of Xmrk ('mrk'), a naturally occuring oncogenic version of the Xiphophorus EGF receptor. HERmrk activates many pathways simultaneously in an otherwise untransformed melanocytic background, including MAP kinase and PI3 kinase pathways. 17 MYC acts synergistically with HERmrk in conveying tumorigenic features to melanocytes c-Myc, from now on simply termed Myc, is a well-established target gene of mammalian EGF receptor and mediates proproliferative and pro-survival effects of this receptor. 18 Figures S1A and B) . In both cases, Myc was equally induced and peaked after 2 h of stimulation. On protein level, Hm hi cells displayed a basal amount of MYC, which, however, could not be further induced by EGF treatment. In Hm me cells MYC was weakly expressed in the unstimulated state, but protein levels strongly increased after EGF addition. We reported previously that the expression level of HERmrk is crucial for determining the outcome in response to EGF stimulation: whereas Hm me cells proliferate because of receptor activation, Hm hi cells become senescent. 16 As MYC has been associated with senescence prevention, 20, 10 we were interested in the effect of MYC overexpression on Hm hi cells. We transfected Hm hi cells with expression plasmids encoding wild-type human MYC (MYC-wt) or the mutant MYC T58A (MYC-TA, Figure 1a ), the latter being more stable than its wildtype counterpart due to a lacking docking site for the ubiquitin ligase Fbw7. 21, 22 Control Hm hi cells did not grow in the absence of EGF and became multinuclear and senescent in the presence of EGF, thereby blocking proliferation (Figures 1b and 2a) (Figure 2b ), as well as the concomitant DNA damage, as determined by DNA comet assay (Figure 2c) .
To investigate the genes associated with the senescencepreventing effect, we performed comparative real-time PCR Figure S2) . In the presence of MYC-TA, induction of p21Cip1/Waf1 was significantly lower. This was not observed for any of the other investigated genes.
Endogenous MIZ1 mediates HERmrk-induced senescence A reduced expression of p21Cip1/Waf1 might be explained by an inhibitory effect of MYC on its interaction partner MIZ1, which is a known inducer of p21Cip1/Waf1 in response to DNA damage. Figure 3a) . Hm hi -pS-Miz1 cells were resistant to EGF-induced senescence (Figure 3b ) and displayed a lack of ROS accumulation and DNA damage (Figures 3c and d) . The experiment was repeated with an independent Miz1 knockdown construct, and similar results were obtained (Supplementary Figures S4A-B) . However, Miz1 knockdown did not show the transforming effects that were observed upon MYC-TA expression: proliferation and soft agar growth were just marginally enhanced in Hm , which mediate cell cycle arrest and senescence. Rather than the expected decrease, we found an increase of both proteins in response to Miz1 knockdown during the first week of treatment, while p21 was undetectable after 2 weeks (Supplementary Figure S5) .
Thus, we concluded that p21-dependent cell cycle control is not the reason for MIZ1-dependent senescence mediation in this model.
CTH is a target gene of MYC and MIZ1 As MYC-TA expression and MIZ1 knockdown inhibit ROS-induced senescence, it is possible that ROS detoxification genes are affected by these transcription factors. We examined the expression of the classical antioxidant genes heme oxygenase (Hmox1), glutathione peroxidase (Gpx1) and peroxiredoxin (Prdx1). Figures  S6A-C) . None of the genes were upregulated by MYC expression or MIZ1 knockdown, but instead, MYC caused a slight but significant downregulation of Hmox1 and Gpx1 (Supplementary Figures S6A,B ). However, with the exception of Prdx1 these genes were not regulated by oxidative stress, as incubation of HERmrk melanocytes with a glutathione ester caused no (Hmox1, Gpx1) or only slight (Prdx1) decrease of these antioxidant genes (Supplementary Figure S6C) .
Hmox1 was already induced by EGF (Supplementary
To identify molecular players that might be causally linked to MYC-and MIZ1-regulated senescence, we performed an mRNA expression microarray analysis. We focused on genes that were upregulated in MYC-TA overexpressing and Miz1 knockdown cells Figure S7) . Most of them are associated with cancer progression. In particular, CTH encodes an enzyme involved in the synthesis of cysteine from methionine, the so-called transsulfuration pathway (TSP). 24 Importantly, MYC and MIZ1 also bind to the human CTH promoter, as we could demonstrate for HeLa cells using chromatin immunoprecipitation analysis (Figure 4b ).
CTH inhibition recovers senescence in MYC-overexpressing and Miz1-depleted cells The shared regulation of CTH by MYC and MIZ1 may be the reason for the reduced oxidative stress, DNA damage and senescence, which are observed in response to MYC-TA overexpression and Miz1 knockdown. Interestingly, Hm hi cells expressed very low levels of CTH protein irrespective of the stimulation state (Figure 4c ). Miz1 knockdown led to a faint induction of CTH protein in the presence of EGF, which was consistent with low transcriptional upregulation (Supplementary Figure S7) . In contrast, MYC-TA strongly induced CTH protein, but only in cooperation with activated HERmrk (Figure 4c ). Cystathionine-bsynthase is the other enzyme required for transsulfuration. It catalyzes the step preceding CTH, namely the generation of cystathionine from homocysteine, 25 and its transcription is affected by cysteine availability. 26 However, the levels of cystathionine-b-synthase protein were similar in Hm hi cells irrespective of EGF stimulation and MYC or MIZ1 expression (Figure 4d) . Similarly, RNA expression of methylene tetrahydrofolate reductase, a component of the TSP-associated remethylation pathway, was unchanged under the different conditions tested (Figure 4e ). These data indicate that regulation of the TSP occurs on the level of CTH. Apart from CTH, cellular cysteine supply is also provided by the cystine glutamate antiporter xCT (also named SLC7A11). 27 Whereas Slc7a11 expression was strongly induced by HERmrk activation, it was not affected by MYC or MIZ1 (Figure 4f) .
The enzymatic activity of CTH can be blocked by propargylglycine (PAG, 28 ). When we applied PAG to EGF-stimulated Hm hi -MYC-TA and Hm hi -pS-Miz1 cells, we observed an increase of senescent cells (Figure 5a) . Importantly, the overexpression of CTH in Hm hi cells prevented senescence induction (Figure 5b) .
OIS, for example, induced by oncogenic RAS, was previously reported to go along with endoplasmic reticulum stress. 29 Interestingly, increased homocysteine levels, which can be the result from a non-functional TSP, can induce endoplasmic reticulum stress and may thus affect senescence. Furthermore, it can lead to ATF4-dependent induction of CTH. 30 We investigated whether homocysteine levels discriminated senescent Hm hi from non-senescent CTH-overexpressing Hm hi cells. We found no differences in homocysteine, but an increase in total glutathione in Hm hi -CTH cells (Supplementary Table S1 ). This indicates that homocysteine levels are most likely not causative for the stressinduced senescence in this pigment cell model. However, as ATF4 is a known inducer of cellular redox proteins and CTH, we tested if MYC and MIZ1 might regulate this transcription factor. Supplementary Figure S8 demonstrates that Atf4 is induced by EGF, but not by MYC expression or Miz1 knockdown.
MYC controls CTH in human melanocytes and melanoma cells So far, our data were collected using murine melanocytes. To test CTH regulation and its role in ROS protection in human pigment cells, we transfected normal human epidermal melanocytes (NHEM) with the MYC overexpression vector pBabe-puro-MYC-TA (Supplementary Figure S9) . MYC expression had no effect on the levels of DNA damage in NHEM cells (Supplementary Figure S9A) , indicating that, similar to the situation in murine cells, no major alterations of ROS levels were caused. However, MYC expression induced a strong induction of CTH levels (Supplementary Figure S9A) . We also generated NHEM cells overexpressing CTH to examine the influence of CTH on ROS sensitivity in primary melanocytes. CTH-transgenic NHEM cells became more resistant to H 2 O 2 -induced DNA damage (Supplementary Figure S9B ) and growth inhibition (Supplementary Figure  S9C) . Importantly, H 2 O 2 exposure alone did not affect CTH levels (Supplementary Figure S9B) . In conclusion, MYC-induced CTH expression is also a feature of human melanocytes.
Human melanoma cells are also subject to high levels of ROS, which need to be tightly controlled to allow tumor propagation. 31 In addition, they usually depend on endogenous MYC. 10 We found that most human melanoma cell lines expressed high levels of MYC and intermediate or high levels of CTH (Figure 6a ). The control human melanocyte cell line Hermes 3a, however, showed no MYC expression and only weak CTH expression. When we knocked down MYC in HeLa cells and five human melanoma cell lines, we found that CTH expression was reduced in four out of six tumor cell lines, confirming the MYC-dependent CTH regulation in these cells (Supplementary Figure S9D) .
Melanoma cells are sensitive to CTH inhibition
To test if CTH is also important for limiting DNA damage in melanoma cells and thereby contributes to senescence prevention, we treated different melanoma cell lines with increasing concentration of PAG. This resulted in increased DNA damage in all cell lines, as the DNA damage markers g-H2AX or P-p53 were strongly induced (Figure 6b and Figure S10A ). In most melanoma cell lines, PAG treatment also led to senescence (Figure 6c and Supplementary Figure S10B ). To find out whether the effect of the inhibitor was CTH-specific, we knocked down CTH in four melanoma cell lines using small interfering RNA (siRNA) and again observed an increase in DNA damage signaling in all cases (Figure 7a ). Besides, proliferation was markedly reduced in response to CTH knockdown, while SA-b-Gal-positive cells with high contents of heterochromatin accumulated (Figure 7b and c, Supplementary Figure S11) . Notably, the cell line UACC-62, harboring an activated AKT pathway due to Phosphatase and Tensin homolog (PTEN) mutation, was particularly sensitive to CTH knockdown. When we supplied additional cystine to the medium of melanoma cells treated with CTH-specific siRNA, the growth was restored (Supplementary Figure S12A) . Importantly, H 2 O 2 sensitivity was dramatically enhanced upon CTH reduction (Figure 7d ), which could be explained by the high requirement for glutathione under stress conditions. While control cells increased their levels of total glutathione in response to H 2 O 2 , cells with reduced CTH were not capable of inducing this adaptive response (Figure 7e ).
CTH can compensate for defective cystine import Murine melanocytes depend on a functional cystine glutamate antiporter, as melan-a sut cells-murine pigment cells harboring deficient Slc7a11-rely on the addition of the antioxidant b-mercaptoethanol to allow proliferation. 32 Interestingly, CTH overexpression in melan-a sut cells was able to compensate for Hence, the cell density in these samples was lower at the timepoint when the picture was taken. As the proliferation potential of PAG-treated cells was strongly reduced due to senescence induction, subcultivation was not necessary here. Scale bar ¼ 100 mm.
Slc7a11 knockout and had an almost similar growth-promoting effect as b-mercaptoethanol (Supplementary Figure S12B) . In human melanoma cells, we observed that cultivation in cystinefree medium strongly upregulated CTH, which explains their cellular tolerance towards cystine withdrawal (Supplementary Figure S12C) . Altogether, these data demonstrate the potency of the TSP in cysteine provision.
Taken together, we identified CTH as a novel MYC/MIZ1 target gene, which proved to be important for intracellular stress reduction, thereby fulfilling a vital function for melanoma cells. Importantly, the specific CTH inhibitor PAG, as well as information on its binding characteristics to the active site are already available, allowing for preclinical elucidation of CTH as possible target in melanoma therapy. 
DISCUSSION
The search for the reasons behind OIS evasion and thus the detection of the tumor's Achilles' heel is essential in order to identify druggable surrogate targets for cancer therapy. Many oncogenes induce senescence, and for some of these factors that bypass this effect and thereby allow tumor growth have been identified. Similar to HERmrk, oncogenic RAS proteins induce high amounts of ROS, leading to senescence. [33] [34] [35] If the accumulation of ROS-induced damage is prevented, as for example, by enforced elimination of oxidized guanine nucleotides, senescence can be inhibited. 36 To keep the ROS levels under control, ROS-induced countermeasures such as the induction of FOXM1 are active in many cells. FOXM1 stimulates the expression of superoxide dismutase, catalase and peroxiredoxins and thus contributes to senescence evasion of human fibroblasts. 37, 38 Interestingly, FOXM1 is a target gene of c-MYC. 39 Furthermore, the transcription factor NRF2 is induced by MYC, leading to the elevation of antioxidant enzymes and thereby lowering the intracellular amount of ROS. 40 These data show that MYC counteracts oxidative stress on multiple levels.
In our studies, we used the murine HERmrk senescence model as a tool for the identification of mediators of senescence evasion. We found that MYC acts synergistically with HERmrk, as it was able to transform EGF-stimulated Hm hi cells. Similar effects occur when MYC is expressed together with oncogenic RAF or RAS, which alone would induce senescence. 10 The potency of MYC to enhance proliferation and induce dedifferentiation is reflected by its role in generating pluripotent stem cells from differentiated adult cells. 41 However, data describing the role of MYC in OIS evasion are only starting to accumulate. Intriguingly, MYC can exert a substantial level of sublethal cellular stress and can thus, under appropriate conditions, lead to OIS itself. As a consequence from aberrant DNA synthesis, MYC is able to induce DNA damage. 42 This is, however, dependent on the cellular context, as we observed no such effect when we overexpressed MYC in murine or human melanocytes. In cells lacking the DNA repair protein WRN, MYC was even found to induce senescence. 43, 44 Recently, CDK2 was identified as another crucial component required to prevent MYC-induced senescence, and Cdk2 knockdown in mice can substantially delay the onset of lymphoma. 20, 45 On one hand, these data indicate that MYC has the capacity to prevent accumulation of intrinsic cellular stress, which would otherwise result in senescence. On the other hand, they show that the senescence program is latently present in some tumor types and can be reactivated. Melanoma cells usually express high levels of MYC, but can be driven into senescence and cellular crisis when the transcription factor is knocked down. 10 Interestingly, the levels of glutathione (GSH) were reported to drop when MYC is inhibited in M14 melanoma cells, resulting in increased ROS levels. 46 Supplementation with the cell permeable cysteine derivative N-acetylcysteine relieved this effect. This reveals two phenomena that are in accordance with our observations: (1) melanoma cells contain an intrinsic source of ROS that can be counteracted, for example, by MYC, (2) the cellular cysteine supply is critical for growth and survival. It has previously been shown for melanoma and other cell types that the genes encoding the rate-limiting enzyme for glutathione (GSH) synthesis, g-glutamyl-cysteinyl synthetase, are induced by MYC. 47, 48 Although g-glutamyl-cysteinyl synthetase levels were not affected by MYC in our model system (see Supplementary Figure S2 ), we could identify the new target gene CTH, whose gene product is rate limiting for the production of cysteine in the TSP. 24 MYC proved to be a strong inducer of CTH in murine HERmrk cells, as well as human NHEM cells. Importantly, it was also involved in CTH regulation in most human tumor cell lines. The fact that CTH inhibition caused melanoma senescence provides another mechanism for MYC-mediated protection from senescence in the respective human melanoma cells.
Through an interaction with MIZ1, MYC can prevent stressinduced induction of cell cycle regulatory genes such as p21CIP1/ WAF1 and p15INK4B and thereby translates DNA damage signals into cell cycle arrest. 13, 49 We observed a higher amount of MIZ1 in senescent Hm hi cells compared with Hm me cells, and knockdown of Miz1 largely prevented senescence. However, this was not accompanied by reduced levels of p21Cip1/Waf1 and p15Ink4B, but instead by an increased amount of Cth transcript. Still, CTH increase was barely seen on protein level, suggesting that CTH is only partly responsible for the senescence-evading effect of Miz1 knockdown in these cells.
Sufficient cysteine levels are the prerequisite for most cellular antioxidant systems, including GSH and taurine. Most cells meet their need for cysteine by importing extracellular cystine via the xCT cystine glutamate antiporter. 27 However, the corresponding gene Slc7a11 was not regulated by MYC or MIZ1, and we showed that CTH expression can compensate for functional loss of Slc7a11. In line with these observations, it was reported that inhibition of xCT only affects viability of melanoma cells if GSH synthesis is blocked simultaneously. 50 It is well known that the TSP, which converts methionine to cysteine, becomes important for cells with particularly strong ROS load. 51 Accordingly, CTH expression is weak in normal human tissue, but increased in tumor cells (http://www.proteinatlas.org/ENSG00000116761). Although an antiproliferative effect of the protein, caused by the increased production of H 2 S, was reported, 52 CTH has pro-tumorigenic functions. 51 Still, only little is known about CTH regulation in tumors. Glutathione depletion and butyrate can stimulate CTH expression in glioma and colon cancer cells, respectively, 53,54 but as CTH levels were not enhanced in our ROS-exposed murine and human pigment cells, ROS do not generally affect CTH levels. Recently, it was demonstrated that the transcription factor ATF4 induces CTH expression in MEF cells exposed to endoplasmic reticulum stress. 30 As ATF4 has an important role in chemoresistance and hypoxia tolerance of tumor cells, 55 it might also be involved in tumor-associated CTH expression. However, MYC is the first tumor-associated transcription factor directly demonstrated to regulate CTH expression.
Importantly, CTH has no essential role in organismal development, as Cth À / À mice develop normally and only adult mice suffer from hypertension. 56 Besides, the mechanism by which PAG inhibits CTH is well-characterized. 28, 57 PAG is applied in mouse models for cardiovascular and nervous system-related diseases associated with H 2 S produced by CTH, and efficiently relieves associated syndromes. 58 However, PAG displays limited membrane permeability, and the development of improved inhibitors is required.
Taken together, CTH is an important cytoprotective protein, which is regulated by MYC. In human melanoma cells, CTH inhibition increases intracellular stress and thereby reinstalls the senescence pathway, rendering it a promising surrogate target for pharmacological intervention and combination melanoma therapy.
MATERIALS AND METHODS

Cell culture
The EGF-inducible version of the oncogenic EGF receptor orthologue Xmrk ('HERmrk' or shortly 'Hm') was described before. 59 For senescence assays, cells were cultured in starving medium (Dulbecco's modified Eagle's medium with 10% dialyzed fetal calf serum (Gibco, Life Technologies, Darmstadt, Germany)) for 3 days before the assay was started. Where indicated, 100 ng/ml human EGF (Tebubio, Offenbach, Germany) or 10 mM D,L-PAG was added. Medium was renewed every second day. Human melanoma cell lines A375, Bro, DX-3, LT5.1, Mel Im, Mel Ho, SK-MEL-3, SK-MEL-28, MeWo and WM-35, as well as HeLa cells were cultivated in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, penicillin (100 U/ml, Gibco), and streptomycin (100 mg/ml, Gibco). The human melanocyte cell line Hermes 3a was cultivated as described. 60 Expression vectors pSuper-Miz1 23 and pBabe-puro-MYC or -MYC T58A61 were described previously. For generation of pBabe-puro-CTH, murine CTH was amplified by PCR, digested with BamHI and SalI and cloned into the pBabe-puro expression vector.
siRNA transfection
Commercially available control siRNA and siRNA against human MYC or CTH (Smart Pool On Target Plus, Thermo Scientific, Dharmacon, Lafayette, CO, USA) was transfected using X-treme gene transfection reagent (Roche, Mannheim, Germany), according to the manufacturer's recommendations. Cells were analyzed 3 days after transfection, if not indicated otherwise. CTH-specific small hairpin RNA (Santa Cruz Biotechnology, Heidelberg, Germany) was delivered to the cells by lentiviral infection as recommended. Cells were selected with 1 mg/ml puromycin before being used for further analyses.
SA-b-Gal staining
Cells were cultured in starving medium for 3 days before they were either left untreated or stimulated with 100 ng/ml EGF every second day. At indicated time points, cells were washed with phosphate-buffered saline (PBS; pH 7.2) and fixed with 3.7% formaldehyde in PBS for 5 min at room temperature. After washing, they were stained in the dark for 12 h at 37 1C (using 1 mg/ml X-Gal, 40 mM citric acid/sodium phosphate buffer (pH 6.0), 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 150 mM NaCl and 2 mM MgCl 2 ). Cells were then washed with PBS and were examined by light microscopy.
Cell lysis and immunoblot analysis
Lysis and blotting procedures were performed as described previously. 16 The following antibodies were used: Anti 
RNA isolation and real-time PCR
RNA isolation was performed with TrIR solution (ABGene). Four microgram of whole RNA was reversely transcribed using the RevertAidTM First Strand cDNA Synthesis Kit (Fermentas, St Leon-Rot, Germany). Fluorescence-based quantitative real-time PCR was performed using the iCycler (Bio-Rad, Munich, Germany). Gene expression was normalized to hypoxanthineguanine phosphoribosyltransferase. Relative expression levels were calculated applying REST software. 62 All oligonucleotides are displayed in Supplementary Table S2. Cell proliferation assay Cells were seeded at equal density onto wells of a 6-well plate and were either left untreated or stimulated with 100 ng/ml EGF and further additives, as stated in the respective figure legends. Cells were harvested by trypsinization at indicated time points, pelleted, resolved in PBS and enumerated manually.
Soft agar growth assay
One millilitre of 1.2% agar was mixed with 1 ml 2 Â Dulbecco's modified Eagle's medium and plated onto 6-well plates. Upon polymerization, the solid agar was overlain with an equal amount of soft agar mix (0.3% agar) containing 4 Â 10 4 cells per well. The polymerized soft agar was supplied with 200 ml of starving media for the controls and the same amount of starving media supplemented with EGF (final concentration per well: 100 ng/ml). This solution was added every second day. After 14 days of cultivation, the number of cell colonies was counted, with 'colony' being defined as more than eight cells per spot.
ROS detection assay
Cells were starved and treated as described for the b-Gal assay. At times indicated, 20 mM 2 0 ,7 0 -dichlorfluorescein-diacetate was added to the medium and cells were stained for 5 min before being washed with PBS and overlain with starving medium. Cells were analyzed microscopically for the presence of ROS-induced 2 0 ,7 0 -dichlorfluorescein (excitation 488 nm).
Comet assay
Cells were pre-starved for 3 days before being either left untreated or stimulated with 100 ng/ml EGF for 14 days. Cells were then trypsinized and used for the assay. Shortly, 2 Â 10 4 cells were mixed with 140 ml of 1% low melting point (LMP) agarose in PBS at 37 1C. The mixture was then transferred as two equal drops to slides pre-coated with 1% standard agarose in H 2 O. Upon polymerization, the slides were put into lysis solution (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris, 1% Triton X-100) for 1 h at 4 1C. Afterwards, the slides were washed three times in enzyme reaction buffer (40 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 0.1 M KCl, 0.5 mM EDTA, 0.2 mg/ml bovine serum albumin, pH 8.0) before treatment with enzyme solution (0.5 mg/ml proteinase K in enzyme reaction buffer) in a moist box for 1 h at 37 1C followed by alkaline treatment in electrophoresis solution (0.3 M NaOH, 1 mM EDTA) for 40 min at 4 1C. Glutathione detection assay Cells were cultivated for 3 days in the presence of 0, 25 or 50 mM H 2 O 2 . Intracellular glutathione was determined according to Tietze. 63 Chromatin immunoprecipitation
The analysis was performed as described previously. 64 The following antibodies were used: MYC (N-262, Santa Cruz Biotechnology) and MIZ1 (M Teichmann, Bordeaux). Precipitated DNA was amplified with specific primers by real-time PCR. The oligonucleotides are displayed in Table S2 .
